BCL2 and non-small cell lung carcinoma: In order to generalize these results, the modulation of selected genes from Hippo pathway after Bcl-2 silencing was also determined in human breast adenocarcinoma, MDA-MB-231, (Fig. 2B-D) and human non-small cell lung cancer, H460, cell lines (Supplementary Figure S3).